Old Web
English
Sign In
Acemap
>
authorDetail
>
Tomoyuki Naito
Tomoyuki Naito
Memorial Hospital of South Bend
Medicine
Cancer research
Metastasis
Anaplastic Lymphoma
Carcinoma
4
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinico-pathological and genomic features of NRAS- or HRAS-mutated non-small cell lung cancer (NSCLC) identified in large-scale genomic screening project (LC-SCRUM-Asia).
2021
Journal of Clinical Oncology
Yutaro Tamiya
Shingo Matsumoto
Takaya Ikeda
Kiyotaka Yoh
Terufumi Kato
Kazumi Nishino
Masahiro Kodani
Atsushi Nakamura
Naoki Furuya
Shoichi Kuyama
Shingo Miyamoto
Ryo Toyozawa
Masato Shingyoji
Tomoyuki Naito
Satoshi Oizumi
Hiroshi Tanaka
Hibiki Udagawa
Kaname Nosaki
Yoshitaka Zenke
Koichi Goto
Show All
Source
Cite
Save
Citations (0)
Treatment of Lung Cancer Targeting MET Alterations
2021
Haigan
Tomoyuki Naito
Hideaki Shiraishi
Yutaka Fujiwara
Show All
Source
Cite
Save
Citations (0)
Durvalumab for the treatment of PD-L1 non-small cell lung cancer
2020
Tomoyuki Naito
Hideaki Shiraishi
Yutaka Fujiwara
Show All
Source
Cite
Save
Citations (1)
Brigatinib and lorlatinib: their effect on ALK inhibitors in NSCLC focusing on resistant mutations and central nervous system metastases.
2020
Japanese Journal of Clinical Oncology
Tomoyuki Naito
Hideaki Shiraishi
Yutaka Fujiwara
Show All
Source
Cite
Save
Citations (2)
1